AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2019
Mar 13, 2019
34519_dirs_2019-03-13_ac14ddaa-b84b-448f-9ec4-27a2d142914e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2019-03-11
Reporting Person: Wainman Paul R (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-11 | Common Stock, par value $0.10 per share | A | 4269.0000 | $4.8000 | Acquired | 6269.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-11 | Incentive Stock Options (Right to buy) | $4.8000 | D | 10731.0000 | Disposed | 2019-03-31 | Common Stock (10731.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23